AzTrials
AzTrials

Sleep DisorderNCT06224972

Evaluation of the Usability and Performance Assessment of the DormoTech VLAB Device as a Home Sleep Test

An observational study of Sleep Disorder, run by Dormotech Medical at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study is a comparative, self-controlled, randomized, prospective investigation designed to assess the usability and accuracy of the DormoTech Vlab and compare its performance with a full polysomnography (PSG) study conducted over one night in a sleep lab. Read more about this study

Who is it for?
Ages 22 years and older
Conditions the study is for
Sleep Disorder
What is being tested?
Vlab
Type of treatment
Medical device
How many people
47 participants
Where
1 siteIsrael
Study dates
13 Jun 2023to 12 Aug 2023
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Subjects were recruited in the sleep clinic by the attending physician, or sub-investigator. The participants were patients who were referred by physicians for a full sleep study at the sleep laboratory.

Who may be able to join

  • Age of 22 years old and above.
  • Willingness and ability to comply with the protocol requirements.
  • Understanding and provision of signed and dated informed consent

Who cannot join

  • Unwillingness to sign informed consent.
  • Age below 22 years.
  • Presence of implanted electronic devices or use of exterior electronic devices during the procedure.
  • Known allergies to device materials.
  • Skin irritation or open wounds at the device placement site.
  • Pregnancy.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Shamir Medical Center

    Be’er Ya‘aqov

Other trials in Israel

About this study

Official title: Usability and Performance Assessment of DormoTech VLAB

The study is a comparative, self-controlled, randomized, prospective investigation designed to assess the usability and accuracy of the DormoTech Vlab and compare its performance with a full polysomnography (PSG) study conducted over one night in a sleep lab. For the purpose of this study, the selected PSG device used for comparison is the Nox A1 system (K192469). Participants were required to wear the DormoTech Vlab, answer questionnaires pre and post-study, and simultaneously undergo a full PSG test using the Nox system.

The statistical methodology for this study was designed to ensure a comprehensive analysis of the data, adhering to the standards set by the International Council for Harmonisation (ICH) E3 guideline

Read the detailed description

The intended use of the V-Lab device is to serve as Type 2 Sleep test, an inexpensive, more comfortable device that can replace the full sleep study in a sleep lab and at-home environment.

The device is composed of three units, two of which are wearable and the third is a central unit responsible for communication; The head unit is worn on the face like a mask, and the body unit is a belt that is worn around the torso. After a few minutes of wearing the device, the patient will become ignorant of its presence. A small rechargeable 3V Li-ion battery operates both units.

The V-Lab system supports the connectivity of peripheral devices for capturing additional signals using Bluetooth technology, e.g. pulse oximeters. The V-Lab device collects and stores physiological signals such as EEG, EOG, EMG, Total Airflow, Snore, Respiratory Effort (Thoracic and Abdominal), Body and Head Position, and HR (derived from Plethysmography) Both the head and chest units communicate with the central units via Bluetooth, and the wearable units send the measured data to the central unit. The central unit receives the data, stores it within an internal flash drive, and transmits it via Wi-Fi to online servers for further diagnosis.

Using the recorded data, a physician can diagnose sleep disorders manually or use any sleep diagnostic system that supports EDF Formats.

The study Objectives are to assess the efficiency, usability, durability, safety, and patient satisfaction of the V-Lab device and to validate the level of agreement between the V-Lab device and a PSG.

The study's main outcome measures are patient feedback as determined by a satisfaction questionnaire, agreement and level of agreement between V-Lab and the referenced device (e.g. Bland-Altman plots of the mean versus the difference will be presented, and sensitivity and specificity analysis), and safety as defined by Adverse Events related to device use.

The study population will include patients seeking medical attention at a sleep clinic, age 22 years old and above and the subject is willing and able to comply with the requirements of the protocol, fully understands all elements of, and has signed and dated, the written informed consent form before initiation of protocol-specified procedures.

The exclusion criteria for the participants are subjects not willing to sign informed consent, subjects age is under 22 years old, subjects with implanted electronic devices of any kind, including cardiac pacemakers, or similar assistive devices, electronic infusion pumps, and implanted stimulators, subjects using exterior electronic devices of any kind during the procedure, such as TENS, or similar assistive devices, subjects with known allergies to device materials, subjects with irritated skin or open wound on the body at the site of device placement, and pregnant women.

Subjects will be recruited on two investigational sites: Shamir Medical Center- Be'er Ya'akov, Israel, and Millennium Sleep Clinic, Be'er Sheva, Israel, by the attending physician.

Subjects will go through a standard PSG monitoring which will be performed with a V-Lab device monitoring simultaneously in the sleep lab during one night.

The subject will be informed that participation in the study is voluntary, that he/she may withdraw from the study at any time and that withdrawal of consent will not affect his/her subsequent medical treatment (if any) or relationship with the treating physician. Subjects will be asked to fill out a satisfaction questionnaire and to report to the investigator Adverse Events.

Before studying active participation, the investigator will perform documentation of demography, relevant medical history, and medication consumption. The investigator will perform also a physical examination, including documentation of relevant medical and surgical history that may affect the experiment, based on the investigator's opinion (including precise diagnosis of disease) and Vital Signs (Pulse, Blood Pressure, Temperature). Steps will be taken to ensure the collected data are accurate, consistent, complete, and reliable.

Conditions
Sleep Disorder
Being tested
Vlab
Keywords
Sleep test, Sleep disorder, Home sleep tests, Physiological data recorder, Sleep diagnostics
Medical subject headings
Sleep Wake Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VlabDevice

    The study is observational, there is no intervention.

Study groups in NCT06224972
Study groupRoleWhat they receive
Observational groupThe study is observational study - one group.
Receives: Device: Vlab

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. AHI Score and Classification

    The AHI (apnea-hypopnea index) score was categorized and compared according to levels of severity:

    AHI = number of Apneas+Hypopneas/total sleep time

    Categorizing Normal <5, Mild: 5<AHI<15, Moderate: 15<AHI<30, Severe: 30<AHI

    Measured: During night 1

Secondary outcomes (8)
  1. Total Sleep Time (min)

    Time from sleep onset to sleep offset (min)

    Measured: During night 1

  2. Sleep Efficiency (%)

    Total sleep time (min) / Total recorded time (min)

    Measured: During night 1

  3. Sleep Stages (%)

    Wake, N1, N2, N3, REM (% from total sleep time)

    Measured: During night 1

  4. Sleep Latency (min)

    Time to fall asleep from the record starting (min)

    Measured: During night 1

  5. Wake After Sleep Onset (min)

    The first wake after sleep onset (min)

    Measured: During night 1

  6. REM Latency (min)

    The amount of time elapsed between the onset of sleep to the first REM stage (min)

    Measured: During night 1

  7. Total snore (%)

    The number of snoring episodes divided by the hours of total sleep time

    Measured: During night 1

  8. Body Position

    Supine position, Left, Right, Up (% from Total Sleep Time)

    Measured: During night 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2024
  2. Study start13 Jun 2023
  3. Primary completion12 Aug 2023
  4. Study completion12 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
47 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT06224972
Sponsor's protocol ID
VLAB_C_T_1
Status last verified
Jan 2024
First submitted
6 Dec 2023
Last updated
25 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Publications

  • Fox BD, Shihab M, Nassir A, Kushinsky D, Barnea O, Tal A. Validation of a novel mask-based device for monitoring of comprehensive sleep parameters and sleep disordered breathing. Sleep Breath. 2025 Jan 20;29(1):83. doi: 10.1007/s11325-025-03250-1.

    PubMed 39833613

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep Disorder, run by Dormotech Medical at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

AHI Score and Classification (time frame: During night 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06224972, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in